RxDoctor Payments Data

Robert Berthold, MD

Psychiatry · Lawndale, CANPI 1114003787

Payments from drug & device makers

$713in general payments, 2019–2025

Across 45 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$288
  • Alkermes, Inc.$181
  • Otsuka America Pharmaceutical, Inc.$121
  • Lundbeck LLC$84
  • Neurocrine Biosciences, Inc.$27
  • Indivior Inc.$12

What the payments were for

  • Food & beverage$713100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$713 in reported general payments places this provider in the 70th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$34,601
Medicare patients
22
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega HafyeraPaliperidone Palmitate18$358,205
Abilify MaintenaAripiprazole58$157,429
Invega TrinzaPaliperidone Palmitate14$112,404
Invega SustennaPaliperidone Palmitate17$55,408
Clozapine OdtClozapine46$52,003
Aripiprazole80$4,864
Clozapine33$3,596
Olanzapine OdtOlanzapine38$2,981
Haloperidol40$2,394
Haloperidol Decanoate17$1,626
Divalproex Sodium26$1,056
Fluphenazine Decanoate12$825
Oxcarbazepine12$653
Divalproex Sodium ErDivalproex Sodium23$621
Benztropine Mesylate33$337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$288$167,81231 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$121$157,42958 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Lawndale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →